This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Digital health companies represented 60% of the sample, the other 40% of which were consulting firms, subsidiaries of providers/payers/lifescience companies and tech corporations, and investors. The research was conducted among 335 respondents, which included 182 digital health companies polled between November 2020 and March 2021.
My guest for this edition is Dave Ryan, Intel GM for Health and LifeSciences at its Internet of Things Group. We spoke at the Connected Health conference in Boston, an annual get-together of innovators in digital health and healthcare transformation which has long been on my list of regular stops on the conference circuit.
My guest for this edition is Dave Ryan, Intel GM for Health and LifeSciences at its Internet of Things Group. We spoke at the Connected Health conference in Boston, an annual get-together of innovators in digital health and healthcare transformation which has long been on my list of regular stops on the conference circuit.
My guest for this edition is Dave Ryan, Intel GM for Health and LifeSciences at its Internet of Things Group. We spoke at the Connected Health conference in Boston, an annual get-together of innovators in digital health and healthcare transformation which has long been on my list of regular stops on the conference circuit.
My guest for this edition is Dave Ryan, Intel GM for Health and LifeSciences at its Internet of Things Group. We spoke at the Connected Health conference in Boston, an annual get-together of innovators in digital health and healthcare transformation which has long been on my list of regular stops on the conference circuit.
My guest for this edition is Dave Ryan, Intel GM for Health and LifeSciences at its Internet of Things Group. We spoke at the Connected Health conference in Boston, an annual get-together of innovators in digital health and healthcare transformation which has long been on my list of regular stops on the conference circuit.
My guest for this edition is Dave Ryan, Intel GM for Health and LifeSciences at its Internet of Things Group. We spoke at the Connected Health conference in Boston, an annual get-together of innovators in digital health and healthcare transformation which has long been on my list of regular stops on the conference circuit.
My guest for this edition is Dave Ryan, Intel GM for Health and LifeSciences at its Internet of Things Group. We spoke at the Connected Health conference in Boston, an annual get-together of innovators in digital health and healthcare transformation which has long been on my list of regular stops on the conference circuit.
My guest for this edition is Dave Ryan, Intel GM for Health and LifeSciences at its Internet of Things Group. We spoke at the Connected Health conference in Boston, an annual get-together of innovators in digital health and healthcare transformation which has long been on my list of regular stops on the conference circuit.
I’ve also scheduled get-togethers with pharma and lifescience folks, health plan people, and execs from consumer health companies. Connected Health and the ATA Conference – covering digital health and value-based care, reimbursement, home care, and clinician/technology partnerships.
Over the past ten days I have been on the road speaking and participating in a number of completely different telemedicine-related meetings including the Canadian Society of Telehealth in Vancouver, Canada, a cellular industry conference in California and the Cartagena Telemedicine Conference in Colombia.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content